0C
021 Capital
Venture CapitalModerate021 Capital is a venture capital investment firm that invests biotechnology, agrotechnology, and the internet.
5
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for 021 Capital.
Investment Thesis & Strategy
021 Capital invests in biotechnology, agrotechnology, and internet companies at various stages. They seek to invest in companies with high growth potential within these sectors.
Investment Activity
Deals per year over the last 6 years
3
20162
20174
20182
20190
20201
2021Portfolio Companies
Selected investments from their portfolio of 5 companies
E
Enko
Biotech · Series A, 2021
C
Cibus
Biotech · Series C+, 2019
L
Lygos
Biotech · Series B, 2019
I
Inscripta
Biotech · Series C+, 2018
P
Provivi
Biotech · Series B, 2018
A
Apeel Sciences
Cleantech · Series C+, 2018
P
Pairwise
Biotech · Series A, 2018
P
Pivot Bio
Cleantech · Series B, 2017
T
Trace Genomics
Biotech · Series A, 2017
Z
Zymergen
Biotech · Series C+, 2016
A
AgBiome
Biotech · Series B, 2016
I
Indigo Agriculture
Cleantech · Series B, 2016
Frequently Asked Questions
021 Capital focuses on Series A, Series B, Series C+ stage investments.